Concepedia

Beiying Dai

BD

6

Publications

337

Citations

6

H-Index

2016

Active since

Affiliations

China Pharmaceutical University(Current)

Nanjing Drum Tower Hospital

Philipps University of Marburg

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Pontificia Universidad Católica Argentina

Beiying Dai is an author at China Pharmaceutical University specializing in immunology, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2016–2024

6

Publications

6

Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL

Tabea Erdmann, Pavel Klener, James T. Lynch et al. · Blood · 2017 · 103 citations · Full text

PLAGL2‐EGFR‐HIF‐1/2α Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity

Weiwei Hu, Shufang Zheng, Haixin Guo et al. · Hepatology · 2020 · 90 citations

B-cell receptor–driven MALT1 activity regulates MYC signaling in mantle cell lymphoma

Beiying Dai, Michael Grau, Mélanie Juilland et al. · Blood · 2016 · 74 citations · Full text

Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer

Yanting Lin, Yiming Liu, Zhenhua Gao et al. · European Journal of Pharmacology · 2023 · 27 citations

, , +10

Chronic Stress Dampens <i>Lactobacillus Johnsonii</i> –Mediated Tumor Suppression to Enhance Colorectal Cancer Progression

Qiuhua Cao, Mingrui Zhao, Yali Su et al. · Cancer Research · 2024 · 26 citations

Rows per page

1–5 of 6